Top Stock Reports for Eli Lilly, Danaher & Citigroup
https://www.zacks.com/commentary/2220146/top-stock-reports-for-eli-lilly-danaher-citigroup?cid=CS-ZC-FT-research_daily-2220146
Feb 02, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Danaher Corporation (DHR) and Citigroup Inc. (C).
0
Here's Why You Should Invest in Boston Scientific (BSX) Now
https://www.zacks.com/stock/news/2223513/here-s-why-you-should-invest-in-boston-scientific-bsx-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2223513
Feb 08, 2024 - Investors are optimistic about Boston Scientific (BSX) on strength across the target market and upbeat guidance.
0
Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down
https://seekingalpha.com/news/4089446-needham-sees-bsx-cnmd-rmd-beating-street-despite-medtech-slow-down?source=feed_sector_healthcare
Apr 14, 2024 - Needham estimates Q1 medtech sales grew less than expected, but that Boston Scientific, CONMED, ResMed and Surmodics should still be able to beat the Street. Read more here.
0
What's in Store for Boston Scientific (BSX) in Q1 Earnings?
https://www.zacks.com/stock/news/2256177/what-s-in-store-for-boston-scientific-bsx-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2256177
Apr 16, 2024 - Boston Scientific (BSX) is expected to have registered strong growth in the Asia Pacific, led by strength in China, Japan and Latin America.
0
Unveiling Boston Scientific (BSX) Q1 Outlook: Wall Street Estimates for Key Metrics
https://www.zacks.com/stock/news/2258362/unveiling-boston-scientific-bsx-q1-outlook-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2258362
Apr 19, 2024 - Beyond analysts' top -and-bottom-line estimates for Boston Scientific (BSX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
0
Boston Scientific (BSX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
https://www.zacks.com/stock/news/2218857/boston-scientific-bsx-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2218857
Jan 31, 2024 - The headline numbers for Boston Scientific (BSX) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
PBH vs. BSX: Which Stock Should Value Investors Buy Now?
https://www.zacks.com/stock/news/2220412/pbh-vs-bsx-which-stock-should-value-investors-buy-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2220412
Feb 02, 2024 - PBH vs. BSX: Which Stock Is the Better Value Option?
0
Why Boston Scientific (BSX) is a Top Momentum Stock for the Long-Term
https://www.zacks.com/stock/news/2234656/why-boston-scientific-bsx-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2234656
Mar 01, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
0
Boston Scientific (BSX) Grows IC Business With New FDA Nod
https://www.zacks.com/stock/news/2235447/boston-scientific-bsx-grows-ic-business-with-new-fda-nod?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2235447
Mar 04, 2024 - The AGENT DCB of Boston Scientific (BSX) is already available in Europe, parts of Asia Pacific and Latin America.
0
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
https://www.zacks.com/stock/news/2240665/are-you-a-growth-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2240665
Mar 14, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
0
Pages: 12
Page 1